Fresenius Group Overview
- The Health Care Group
-
Stories
-
![]()
Fresenius Medical Care celebrates first 20 years
-
![]()
Ready to help the littlest ones
-
![]()
A vast island nation
-
![]()
Making mistakes to avoid them
-
![]()
"I want to help others, so they won’t give up"
-
![]()
17,962 miles halfway around the world
-
![]()
A polyclinic in Ghana
-
![]()
Dialysis patient succeeds in giving birth
-
![]()
The future is purple
-
![]()
Returning a hospital to health in Germany
-
![]()
Helping patients to conquer illiteracy and learn for life
-
![]()
From a local pharmacy to a global corporation
-
- Investors
-
Media
![]()
Contact
Matthias Link
Vice President Corporate Communications
T: +49 (0) 6172 608-2872
matthias.link@fresenius.com - Careers
Fresenius Medical Care celebrates first 20 years
Ready to help the littlest ones
A vast island nation
Making mistakes to avoid them
"I want to help others, so they won’t give up"
17,962 miles halfway around the world 
A polyclinic in Ghana
Dialysis patient succeeds in giving birth
The future is purple
Returning a hospital to health in Germany
Helping patients to conquer illiteracy and learn for life
From a local pharmacy to a global corporation
-
Making mistakes to avoid them
Simulating the symptoms of patients in crisis, life-like mannequins help create a high-pressure but highly valuable training opportunity for doctors and nurses at Fresenius Helios.
Read the story -
Forward Thinking Healthcare
Watch our image film, which explains in under 5 minutes who Fresenius is and what Fresenius does.
Watch the Fresenius image film -
Ready to help the littlest ones
Some children have to fight for life, right from birth: A day on the Neonatology ward of HELIOS Hospital Schwerin, Germany.
Read the story -
A vast island nation
Fresenius Medical Care employees are helping to promote the expansion of the health care system in Indonesia – even in remote parts of the island nation.
Read the story
News
-
![]()
![]()
-
![]()
![]()
-
![]()
Brief NewsFresenius' Investment Grade Rating remains unaffected
Following Fresenius’ announcement to acquire Akorn, Inc. and Merck KGaA’s biosimilars business, the rating agencies Standard & Poor’s (BBB-, stable), Moody’s (Baa3, stable) and Fitch (BBB-, stable) confirm the corporate credit ratings of Fresenius to be unaffected.
April 26, 2017Fresenius
-
![]()
Brief NewsFresenius Kabi USA wins supplier award from Vizient
Fresenius Kabi USA has won the prestigious 2016 Pharmaceutical Supplier of the Year Award from Vizient Inc., the largest group purchasing organization for U.S. academic medical centers, community hospitals, pediatric facilities, integrated health delivery networks and non-acute health care providers. Fresenius Kabi has won six Vizient awards for service excellence in recent years.
April 24, 2017Fresenius Kabi
- Brief News
Fresenius Vamed wins contract for university hospital building in Austria
Fresenius Vamed will realize a 350-bed building at University Hospital St. Pölten, in Austria. Working with a partner company, Fresenius Vamed will be the general contractor on the €176 million project. The new building will have some 21,000 square meters (226,000 square feet) of floor space, housing a range of specialist wards. Construction is scheduled to begin in 2019.
April 21, 2017Fresenius Vamed
Brief NewsFresenius Helios modernizing hospital in central Germany
Fresenius Helios is investing €14 million to modernize its hospital in Wipperfürth, North Rhine-Westphalia. Starting late this month, two wards will be completely renovated and expanded, with three delivery rooms to follow. To minimize disruptions to hospital operations, the individual renovations are being carried out in sequence. When completed in early 2019, they will provide more comfort for patients and reduce the distances that need to be walked inside the hospital.
April 06, 2017Fresenius Helios
- Brief News
Fitch rates Fresenius Finance Ireland Bonds at BBB- and affirms Fresenius at BBB-
Fitch Ratings has assigned Fresenius Finance Ireland’s €2,600 million notes issued to finance the acquisition of Quirónsalud an instrument rating of BBB-. It also affirmed Fresenius’ corporate credit rating at BBB-. The outlook is stable. The €2,600 million notes were drawn under the newly established Fresenius European Medium Term Note (EMTN) Program and issued by Fresenius Finance Ireland plc., a wholly owned subsidiary of Fresenius SE & Co. KGaA.
March 23, 2017Fresenius
Brief NewsFresenius Helios opens new hospital building in Duisburg
Fresenius Helios has opened the new building at its hospital in the western German city of Duisburg. The 22,000-square-meter (237,000-square-foot) structure will accommodate up to 350 inpatients. Construction took two years, with Fresenius Helios investing €50 million in the new building. The move from the existing facility into the new building will start later this month.
March 20, 2017Fresenius Helios
- Brief News
Quirónsalud to build Spain’s first proton beam therapy center
Quirónsalud, a unit of Fresenius Helios, is investing about €40 million to build a proton beam therapy center in Madrid. Scheduled for opening in 2019, it will be the first facility of this type for treating cancer patients in Spain. Currently, every patient who can benefit from proton beam therapy must seek treatment outside the country. In proton beam therapy, the use of a high-energy beam allows tumors to be irradiated with lower total doses of radiation and reduced exposure to surrounding tissue compared with conventional radiation therapy. Quirónsalud will also modernize and expand its radiotherapy clinics in Palmaplanas (Mallorca) and Seville.
March 10, 2017Fresenius Helios
![]()
-
![]()
![]()
-
![]()
Initial conversion price of equity-neutral convertible bonds fixed
February 02, 2017Fresenius
-
![]()
Fresenius Medical Care reaches agreement on outstanding payments
January 31, 2017Fresenius Medical Care
-
U.S. District Court Issues Preliminary Injunction Against Premium Assistance Regulation
January 26, 2017Fresenius Medical Care
Fresenius successfully places equity-neutral convertible bonds
January 19, 2017Fresenius
-
Fresenius announces issuance of equity-neutral convertible bonds
January 19, 2017Fresenius
![]()
-
![]()
Statement of Fresenius Medical Care Regarding Lawsuit Challenging Premium Assistance Regulation: U.S. Court Ruling Granting Temporary Restraining Order
January 13, 2017Fresenius Medical Care
-
Statement of Fresenius Medical Care Regarding Lawsuit Challenging Premium Assistance Regulation
January 07, 2017Fresenius Medical Care
![]()
- Brief News
Schuldschein Loans of €1 billion placed
Fresenius successfully placed €1.0 billion of Schuldschein Loans. Given the substantial investor demand, the volume of the issuance was significantly upsized. The Schuldschein Loans were issued in tranches of five, seven and ten years with fixed and variable interest rates. The proceeds will be used general corporate purposes and the acquisition of Quirónsalud. Funding of the transaction will be on January 31, 2017. More than 230 investors participated. The placement was arranged by Bayerische Landesbank, Deutsche Bank AG, DZ BANK and NORD/LB Norddeutsche Landesbank Girozentrale.
December 20, 2016Fresenius
![]()
-
![]()
Import (ICS)August 01, 2017 | Bad Homburg, Germany
Conference Call Q2 2017, Fresenius
Live webcast
Social Media
Library
-
![]()
Annual Report 2016 (US-GAAP) (PDF, 2.89 MB)
-
![]()
Fresenius "At a Glance" (PDF, 344 KB)
-
![]()
Book "100 Years of Fresenius" (PDF, 6.25 MB)
-
![]()
Fresenius Factsheet Q1/2017 (PDF, 458 KB)
-
![]()
Fresenius Medical Care "Profile" (PDF, 368 KB)
-
![]()
Fresenius Medical Care Magazine "Living Knowledge" (PDF, 2.66 MB)
-
![]()
Social Media Guidelines (PDF, 1.97 MB)
-
![]()
Investor Relations General Presentation (PDF, 581 KB)
Contact us
Fresenius SE & Co. KGaA
Else-Kröner-Str. 1
61352 Bad Homburg v.d.H.
Germany
T +49 (0) 6172 608-0
pr-fre@fresenius.com
Contact
